1
|
Mirdamadi A, Abrishamkar R, Kargaran A. Comparing outcomes of clonidine and captopril in patients with hypertensive urgency: A randomized clinical trial. ARYA ATHEROSCLEROSIS 2022; 18:1-6. [PMID: 36818154 PMCID: PMC9931607 DOI: 10.48305/arya.v18i1.2146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Accepted: 05/12/2021] [Indexed: 02/24/2023]
Abstract
BACKGROUND Hypertension (HTN) is the second leading risk factor for death and disability. One fourth of healthcare in Eastern Europe and Central Asia is being spent on blood pressure (BP)-related diseases. An important situation in patients with high BP is hypertensive crisis (BP > 180/120 mmHg), which is divided to hypertensive emergency and urgency. Therefore, here, we decided to compare the effect of captopril and clonidine in patients with hypertensive urgencies, and their side effects. METHODS This was a parallel-group randomized clinical trial. Patients, who referred to emergency ward with any symptoms of hypertensive crisis, underwent a careful history taking and clinical examination. Individuals with systolic BP (SBP) ≥ 180 mmHg or diastolic BP (DBP) ≥ 110 mmHg with no evidence of end organ damage were randomly assigned into two interventions, clonidine and captopril. 25% decrease in BP was considered as ideal relief. RESULTS Regarding the duration of response to treatment drugs, patients who received clonidine relieved significantly faster than those who received captopril (P = 0.016). Moreover, the frequencies of side effects such as headache, dizziness/vertigo, dry mouth, and drowsiness in the clonidine group were significantly lower than captopril group (P < 0.05). CONCLUSION Patients in clonidine group relieved sooner and experienced fewer side effects. Therefore, this study suggests clonidine as a more effective therapeutic for hypertensive urgency compared with captopril.
Collapse
Affiliation(s)
- Ahmad Mirdamadi
- Associate Professor, Department of Cardiology, Najafabad Branch, Islamic Azad University, Isfahan, Iran
| | - Rana Abrishamkar
- Medical Practitioner, Najafabad Branch, Islamic Azad University, Isfahan, Iran,Address for correspondence: Rana Abrishamkar; Medical Practitioner, Najafabad Branch, Islamic Azad University, Isfahan, Iran
| | - Afrooz Kargaran
- Medical Practitioner, Najafabad Branch, Islamic Azad University, Isfahan, Iran
| |
Collapse
|
2
|
Andualem A, Liknaw T, Edmealem A, Gedefaw M. Adherence to antihypertensive medications among adult hypertensive patients attending chronic follow-up units of Dessie Referral Hospital, Northeastern Ethiopia: A cross-sectional study. Medicine (Baltimore) 2021; 100:e26818. [PMID: 34397841 PMCID: PMC8341316 DOI: 10.1097/md.0000000000026818] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Accepted: 07/16/2021] [Indexed: 11/25/2022] Open
Abstract
Hypertension is the leading cause of increased morbidity and mortality rates worldwide. Despite adherence to therapies is the important determinant of treatment success to reduce apparent resistant hypertension, maintaining good adherence to antihypertensive medications remained the most serious challenge. Thus, this study aimed to assess adherence to antihypertensive medications among adult hypertensive patients in Dessie Referral Hospital.A cross-sectional study design was conducted among hypertensive patients during May and June 2020. The study participants were selected using a systematic random sampling technique. The collected data were entered into EpiData version 4.4 and exported to SPSS version 25.0 software for data cleaning and analysis. Data were analyzed using bivariable and multivariable logistic regression at a 95% confidence interval (CI). A variable that has a P-value < .05 was declared as statistically significant. Hosmer-Lemeshow test was used to test goodness-of-fit and multicollinearity was tested.The overall good adherence to antihypertensive medications was 51.9%; 95% CI: (46.8-58.3%) and poor adherence was 48.1%. Factors associated with good adherence were: sex-female adjusted odd ratio (AOR) = 1.31; 95% CI (1.06-2.52), occupational status-employed AOR = 2.24; 95% CI (1.33-3.72), good knowledge of the disease AOR = 2.20; 95% CI (1.34-3.72) and good self-efficacy AOR = 1.38; 95% CI (1.20-2.13).This study revealed that almost half of the hypertensive patients in Dessie Referral Hospital had good antihypertensive medication adherence. Sex, occupational status, knowledge, and self-efficacy were factors associated with good adherence. Therefore, health education should be given to patients on the importance of complying with medication and patients should be monitored by health extension workers.
Collapse
Affiliation(s)
- Atsedemariam Andualem
- Department of Nursing, School of Nursing and Midwifery, Wollo University, Dessie, Ethiopia
| | - Tiliksew Liknaw
- Department of Nursing, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia
| | - Afework Edmealem
- Department of Nursing, School of Nursing and Midwifery, Wollo University, Dessie, Ethiopia
| | - Mihretie Gedefaw
- Department of Nursing, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia
| |
Collapse
|
3
|
Salazar MR, Garcia Vazquez F, Espeche WG, Marquez D, Becerra P, Martinez Marissi E, Sorasio VB, Staffieri GJ, Kalbermatter A, De Cerchio AE, Beaney T, Partington G, Poulter NR, Marín MJ, Ennis IL. May Measurement Month 2019: an analysis of blood pressure screening results from Argentina. Eur Heart J Suppl 2021; 23:B12-B14. [PMID: 34248428 PMCID: PMC8263082 DOI: 10.1093/eurheartj/suab055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The Argentinean Society of Hypertension, in agreement with the May Measurement Month (MMM) initiative of the International Society of Hypertension, implemented for the third consecutive year a hypertension screening campaign. A volunteer cross-sectional survey was carried out in public spaces and health centres during the month of May 2019 across 33 cities in Argentina. Hypertension was defined as systolic blood pressure (BP) ≥140 mmHg and/or diastolic BP ≥90 mmHg based on the mean of the second and third BP measurements, or in those on treatment for high BP. A total of 94 523 individuals (53.9 ± 17.8 years old, 55 231women and 39 292 men), were evaluated. The age and sex standardized mean BP was 124.7/77.2 mmHg. Among participants, 34.7% were overweight (25-29.9 m/kg2) and 28.7% had obesity (≥30 m/kg2). Individuals identified as being overweight had BP 3/2 mmHg higher and individuals with obesity 6/4 mmHg higher than those with normal weight. The prevalence of hypertension was 52.5%. Although 81.1% were aware and 77.7% were on antihypertensive treatment, only 46.0% of all individuals with hypertension had their BP controlled. Moreover, 19.8% of those not on any antihypertensive medication were found with raised BP. The low level of control of hypertension generates the critical need for the development of community-based prevention strategies reinforcing strategies to increase the awareness and control of hypertension.
Collapse
Affiliation(s)
- Martin R Salazar
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Fortunato Garcia Vazquez
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Walter G Espeche
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Diego Marquez
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Pedro Becerra
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Evangelina Martinez Marissi
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Viviana B Sorasio
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Gustavo J Staffieri
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Arnoldo Kalbermatter
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Alejandro E De Cerchio
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Thomas Beaney
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.,Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK
| | - Giles Partington
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK
| | - Neil R Poulter
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK
| | - Marcos J Marín
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| | - Irene L Ennis
- Sociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina
| |
Collapse
|
4
|
Campbell NR, Schutte AE, Varghese CV, Ordunez P, Zhang XH, Khan T, Sharman JE, Whelton PK, Parati G, Weber MA, Orías M, Jaffe MG, Moran AE, Plavnik FL, Ram VS, Brainin M, Owolabi MO, Ramirez AJ, Barbosa E, Bortolotto LA, Lackland DT. [São Paulo call to action for the prevention and control of high blood pressure: 2020Llamado a la acción de San Pablo para la prevención y el control de la hipertensión arterial, 2020]. Rev Panam Salud Publica 2021; 44:e27. [PMID: 33643393 PMCID: PMC7905737 DOI: 10.26633/rpsp.2021.27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Accepted: 11/05/2019] [Indexed: 11/24/2022] Open
Abstract
About 1/4th of adults have high blood pressure which is the single most important risk for death (including heart disease and stroke).There are effective policies that could facilitate people making healthy choices to prevent raised blood pressure, and if fully implemented, could largely prevent hypertension from occurring.Hypertension is easy to screen and treat for BUT only about 50% of adults with hypertension are aware of their condition and only about 1 in 7 is adequately treated.Preventing and controlling high blood pressure is the major mechanism for NCD prevention and control and a model for other NCD risks.Effective lifestyle and drug treatments could prevent and control hypertension in most individuals if systematically applied to the population, simple interventions are feasible in all settings, and can be used to enhance primary care.Urgent sustained action is needed is needed for effective public policies and health system changes to prevent and control hypertension.
Collapse
Affiliation(s)
- Norm Rc Campbell
- Departamento de Medicina, Departamento de Medicina, Fisiologia e Farmacologia e Ciências da Saúde da Comunidade, Instituto O'Brien de Saúde Pública e Instituto Cardiovascular Libin de Alberta, Universidade de Calgary Alberta Canadá Departamento de Medicina, Departamento de Medicina, Fisiologia e Farmacologia e Ciências da Saúde da Comunidade, Instituto O'Brien de Saúde Pública e Instituto Cardiovascular Libin de Alberta, Universidade de Calgary, Calgary, Alberta, Canadá
| | - Aletta E Schutte
- Unidade de Hipertensão e Doença Cardiovascular, Equipe de Pesquisa de Hipertensão na África (HART, na sigla em inglês), Universidade Noroeste Potchefstroom África do Sul Unidade de Hipertensão e Doença Cardiovascular, Equipe de Pesquisa de Hipertensão na África (HART, na sigla em inglês), Universidade Noroeste, Potchefstroom, África do Sul
| | - Cherian V Varghese
- Departamento de Doenças Não Transmissíveis, Organização Mundial da Saúde Genebra Suíça Departamento de Doenças Não Transmissíveis, Organização Mundial da Saúde, Genebra, Suíça
| | - Pedro Ordunez
- Departamento de Doenças Não Transmissíveis e Saúde Mental, Organização Pan-Americana da Saúde Washington, D.C. Estados Unidos Departamento de Doenças Não Transmissíveis e Saúde Mental, Organização Pan-Americana da Saúde, Washington, D.C., Estados Unidos
| | - Xin-Hua Zhang
- Instituto Liga de Hipertensão de Pequim Pequim China Instituto Liga de Hipertensão de Pequim, Pequim, China
| | - Taskeen Khan
- Departamento de Doenças Não Transmissíveis, Organização Mundial da Saúde Genebra Suíça Departamento de Doenças Não Transmissíveis, Organização Mundial da Saúde, Genebra, Suíça
| | - James E Sharman
- Instituto Menzies para Pesquisa Médica, Universidade da Tasmânia, Hobart Tasmânia Austrália Instituto Menzies para Pesquisa Médica, Universidade da Tasmânia, Hobart, Tasmânia, Austrália
| | - Paul K Whelton
- Departamento de Epidemiologia e Medicina, Centro de Ciências da Saúde da Universidade de Tulane Nova Orleans Estados Unidos Departamento de Epidemiologia e Medicina, Centro de Ciências da Saúde da Universidade de Tulane, Nova Orleans, Estados Unidos
| | - Gianfranco Parati
- Departamento de Medicina e Cirurgia, Universidade de Milão-Bicocca e Departamento de Ciências Cardiovasculares, Neurais e Metabólicas, e Instituto Auxológico Italiano, IRCCS, Hospital San Luca Milão Itália Departamento de Medicina e Cirurgia, Universidade de Milão-Bicocca e Departamento de Ciências Cardiovasculares, Neurais e Metabólicas, e Instituto Auxológico Italiano, IRCCS, Hospital San Luca, Milão, Itália
| | - Michael A Weber
- Divisão de Medicina Cardiovascular, Universidade Estadual de Nova York, Centro Médico Downstate, Brooklyn Nova York Estados Unidos Divisão de Medicina Cardiovascular, Universidade Estadual de Nova York, Centro Médico Downstate, Brooklyn, Nova York, Estados Unidos
| | - Marcelo Orías
- Sanatorio Allende, y Universidade Nacional de Córdoba Córdoba Argentina Sanatorio Allende, y Universidade Nacional de Córdoba, Córdoba, Argentina
| | - Marc G Jaffe
- Resolve to Save Lives, Uma Iniciativa da Vital Strategies, Nova York, Estados Unidos e Kaiser Permanente do Norte da Califórnia, South San Francisco Califórnia Estados Unidos Resolve to Save Lives, Uma Iniciativa da Vital Strategies, Nova York, Estados Unidos e Kaiser Permanente do Norte da Califórnia, South San Francisco, Califórnia, Estados Unidos
| | - Andrew E Moran
- Controle Mundial de Hipertensão, Resolve to Save Lives, Uma iniciativa da Vital Strategies Nova York Estados Unidos Controle Mundial de Hipertensão, Resolve to Save Lives, Uma iniciativa da Vital Strategies, Nova York, Estados Unidos
| | - Frida Liane Plavnik
- Grupo de Hipertensão, Hospital Alemão Oswaldo Cruz; Instituto do Coração (InCor); Sociedade Brasileira de Hipertensão São Paulo Brasil Grupo de Hipertensão, Hospital Alemão Oswaldo Cruz; Instituto do Coração (InCor); Sociedade Brasileira de Hipertensão, São Paulo, Brasil
| | - Venkata S Ram
- Escola de Medicina Sudoeste da Universidade do Texas, Dallas, Estados Unidos; Faculdade de Medicina e Hospitais Apollo Hyderabad Índia Escola de Medicina Sudoeste da Universidade do Texas, Dallas, Estados Unidos; Faculdade de Medicina e Hospitais Apollo, Hyderabad, Índia; Universidade Macquarie, Faculdade de Medicina e Ciências da Saúde, Sydney, Austrália; Liga Mundial de Hipertensão, Escritório Regional do Sudeste Asiático, Hyderabad, Índia
| | - Michael Brainin
- Universidade do Danúbio Krems Áustria Universidade do Danúbio, Krems, Áustria
| | - Mayowa O Owolabi
- Centro de Excelência para Doenças Não Transmissíveis da Aliança de Universidades de Pesquisa Africana Universidade de Ibadan Nigéria Centro de Excelência para Doenças Não Transmissíveis da Aliança de Universidades de Pesquisa Africana, Universidade de Ibadan, Nigéria
| | - Agustin J Ramirez
- Unidade de Hipertensão Arterial e Doenças Metabólicas, Hospital Universitário, Fundação Favaloro Buenos Aires Argentina Unidade de Hipertensão Arterial e Doenças Metabólicas, Hospital Universitário, Fundação Favaloro, Buenos Aires, Argentina
| | - Eduardo Barbosa
- Sociedade Latino-americana de Hipertensão Porto Alegre Brasil Sociedade Latino-americana de Hipertensão, Porto Alegre, Brasil
| | - Luiz Aparecido Bortolotto
- Hospital das Clínicas da Universidade de São Paulo; Instituto do Coração (InCor); e Sociedade Brasileira de Hipertensão São Paulo Brasil Hospital das Clínicas da Universidade de São Paulo; Instituto do Coração (InCor); e Sociedade Brasileira de Hipertensão, São Paulo, Brasil
| | - Daniel T Lackland
- Divisão de Neurociências Translacionais e Estudos Populacionais, Universidade de Medicina da Carolina do Sul Charleston Estados Unidos Divisão de Neurociências Translacionais e Estudos Populacionais, Universidade de Medicina da Carolina do Sul, Charleston, Estados Unidos
| |
Collapse
|
5
|
Campbell NRC, Schutte AE, Varghese CV, Ordunez P, Zhang XH, Khan T, Sharman JE, Whelton PK, Parati G, Weber MA, Orías M, Jaffe MG, Moran AE, Plavnik FL, Ram VS, Brainin M, Owolabi MO, Ramirez AJ, Barbosa E, Bortolotto LA, Lackland DT. [São Paulo call to action for the prevention and control of high blood pressure: 2020Chamado à ação de São Paulo para prevenção e controle da hipertensão arterial: 2020]. Rev Panam Salud Publica 2021; 45:e26. [PMID: 33643404 PMCID: PMC7905751 DOI: 10.26633/rpsp.2021.26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Accepted: 11/05/2019] [Indexed: 11/24/2022] Open
Abstract
About 1/4th of adults have high blood pressure which is the single most important risk for death (including heart disease and stroke).There are effective policies that could facilitate people making healthy choices to prevent raised blood pressure, and if fully implemented, could largely prevent hypertension from occurring.Hypertension is easy to screen and treat for BUT only about 50% of adults with hypertension are aware of their condition and only about 1 in 7 is adequately treated.Preventing and controlling high blood pressure is the major mechanism for NCD prevention and control and a model for other NCD risks.Effective lifestyle and drug treatments could prevent and control hypertension in most individuals if systematically applied to the population, simple interventions are feasible in all settings, and can be used to enhance primary care.Urgent sustained action is needed is needed for effective public policies and health system changes to prevent and control hypertension.
Collapse
Affiliation(s)
- Norm RC Campbell
- Departamento de Medicina, Fisiología y Farmacología y Ciencias de la Salud de la Comunidad, Instituto O’Brien para Salud Pública e Instituto Cardiovascular Libin de Alberta, Universidad de CalgaryCalgary, AlbertaCanadáDepartamento de Medicina, Fisiología y Farmacología y Ciencias de la Salud de la Comunidad, Instituto O’Brien para Salud Pública e Instituto Cardiovascular Libin de Alberta, Universidad de Calgary, Calgary, Alberta, Canadá
| | - Aletta E Schutte
- Unidad para la Hipertensión y las Enfermedades Cardiovasculares, Equipo de Investigación de la Hipertensión en África (HART), Universidad NoroccidentalPotchefstroomSudáfricaUnidad para la Hipertensión y las Enfermedades Cardiovasculares, Equipo de Investigación de la Hipertensión en África (HART), Universidad Noroccidental, Potchefstroom, Sudáfrica
| | - Cherian V Varghese
- Departamento de Enfermedades no Transmisibles, Organización Mundial de la SaludGinebraSuizaDepartamento de Enfermedades no Transmisibles, Organización Mundial de la Salud, Ginebra, Suiza
| | - Pedro Ordunez
- Departamento de Enfermedades no Transmisibles y Salud Mental, Organización Panamericana de la SaludWashington, D.C.Estados UnidosDepartamento de Enfermedades no Transmisibles y Salud Mental, Organización Panamericana de la Salud, Washington, D.C., Estados Unidos
| | - Xin-Hua Zhang
- Instituto de la Liga de Beijing contra la HipertensiónBeijingChinaInstituto de la Liga de Beijing contra la Hipertensión, Beijing, China
| | - Taskeen Khan
- Departamento de Enfermedades no Transmisibles, Organización Mundial de la SaludGinebraSuizaDepartamento de Enfermedades no Transmisibles, Organización Mundial de la Salud, Ginebra, Suiza
| | - James E Sharman
- Instituto Menzies de Investigación Médica, Universidad de TasmaniaHobartTasmaniaAustraliaInstituto Menzies de Investigación Médica, Universidad de Tasmania, Hobart, Tasmania, Australia
| | - Paul K Whelton
- Departamentos de Epidemiología y Medicina, Centro de Ciencias Médicas de la Universidad de TulaneNueva OrleansEstados UnidosDepartamentos de Epidemiología y Medicina, Centro de Ciencias Médicas de la Universidad de Tulane, Nueva Orleans, Estados Unidos
| | - Gianfranco Parati
- Departamento de Medicina y Cirugía, Universidad de Milán-Bicocca, y Departamento de Ciencias Cardiovasculares, Neurales y Metabólicas, Instituto Auxológico Italiano, IRCCS, Hospital San LucaMilánItaliaDepartamento de Medicina y Cirugía, Universidad de Milán-Bicocca, y Departamento de Ciencias Cardiovasculares, Neurales y Metabólicas, Instituto Auxológico Italiano, IRCCS, Hospital San Luca, Milán, Italia
| | - Michael A Weber
- División de Medicina Cardiovascular, Universidad Estatal de Nueva York, Centro Médico DownstateBrooklynNueva YorkEstados UnidosDivisión de Medicina Cardiovascular, Universidad Estatal de Nueva York, Centro Médico Downstate, Brooklyn, Nueva York, Estados Unidos
| | - Marcelo Orías
- Sanatorio Allende, y Universidad Nacional de CórdobaCórdobaArgentinaSanatorio Allende, y Universidad Nacional de Córdoba, Córdoba, Argentina
| | - Marc G Jaffe
- Resolve to Save Lives, una iniciativa de Vital Strategies, Nueva York, Estados Unidos y Kaiser Permanente de California del Norte, San Francisco meridionalCaliforniaEstados UnidosResolve to Save Lives, una iniciativa de Vital Strategies, Nueva York, Estados Unidos y Kaiser Permanente de California del Norte, San Francisco meridional, California, Estados Unidos
| | - Andrew E Moran
- Control Mundial de la Hipertensión, Resolve to Save Lives, una iniciativa de Vital StrategiesNueva YorkEstados UnidosControl Mundial de la Hipertensión, Resolve to Save Lives, una iniciativa de Vital Strategies, Nueva York, Estados Unidos
| | - Frida Liane Plavnik
- Grupo de Hipertensión, Hospital Alemão Oswaldo Cruz; e Instituto del Corazón (InCor); y Sociedad Brasileña de HipertensiónSan PabloBrasilGrupo de Hipertensión, Hospital Alemão Oswaldo Cruz; e Instituto del Corazón (InCor); y Sociedad Brasileña de Hipertensión, San Pablo, Brasil)
| | - Venkata S Ram
- Escuela de Medicina Sudoeste de la Universidad de Texas, Estados Unidos; Colegio Médico y Hospital ApolloHyderabadIndiaFacultad de Medicina y Ciencias de la Salud de la Universidad de MacquarieSydneyAustraliaOficina Regional de Asia Meridional de la Liga Mundial de la HipertensiónHyderabadIndiaEscuela de Medicina Sudoeste de la Universidad de Texas, Estados Unidos; Colegio Médico y Hospital Apollo, Hyderabad, India; Facultad de Medicina y Ciencias de la Salud de la Universidad de Macquarie, Sydney, Australia; Oficina Regional de Asia Meridional de la Liga Mundial de la Hipertensión, Hyderabad, India
| | - Michael Brainin
- Universidad del DanubioKremsAustriaUniversidad del Danubio, Krems, Austria
| | - Mayowa O Owolabi
- Centro de Excelencia de las Universidades Africanas de Investigación sobre las Enfermedades no TransmisiblesUniversidad de IbadanNigeriaCentro de Excelencia de las Universidades Africanas de Investigación sobre las Enfermedades no Transmisibles, Universidad de Ibadan, Nigeria
| | - Agustin J Ramirez
- Unidad de Hipertensión Arterial y Enfermedades Metabólicas, Hospital Universitario, Fundación FavaloroBuenos AiresArgentinaUnidad de Hipertensión Arterial y Enfermedades Metabólicas, Hospital Universitario, Fundación Favaloro, Buenos Aires, Argentina
| | - Eduardo Barbosa
- Sociedad Latinoamericana de la Hipertensión, Artery LatamPorto AlegreBrasilSociedad Latinoamericana de la Hipertensión, Artery Latam, Porto Alegre, Brasil
| | - Luiz Aparecido Bortolotto
- Hospital de Clínicas, Universidad de San Pablo; Instituto del Corazón; y Sociedad Brasileña de HipertensiónSan PabloBrasilHospital de Clínicas, Universidad de San Pablo; Instituto del Corazón; y Sociedad Brasileña de Hipertensión, San Pablo, Brasil
| | - Daniel T Lackland
- División de Neurociencias Aplicadas y Estudios de Población, Universidad Médica de Carolina del Sur, CharlestonCarolina del SurEstados UnidosDivisión de Neurociencias Aplicadas y Estudios de Población, Universidad Médica de Carolina del Sur, Charleston, Carolina del Sur, Estados Unidos
| |
Collapse
|
6
|
Feldman RD, Padwal RS, Tobe SW. The Rise and Fall of Hypertension Control in Canada: The Beginning of the End or the End of the Beginning? Can J Cardiol 2021; 37:679-682. [PMID: 33607230 DOI: 10.1016/j.cjca.2021.02.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Revised: 02/07/2021] [Accepted: 02/08/2021] [Indexed: 10/22/2022] Open
Affiliation(s)
- Ross D Feldman
- Cardiac Sciences, St Boniface Hospital, Winnipeg, Manitoba, Canada; University of Manitoba, Winnipeg, Manitoba, Canada.
| | - Raj S Padwal
- Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
| | - Sheldon W Tobe
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Northern Ontario School of Medicine, Sudbury, Ontario, Canada
| |
Collapse
|
7
|
Cai F, Dong WY, Jiang JX, Chen XL, Wang Y, Deng CY, Zhang QY. Estimation of salt intake assessed by 24-h urinary sodium level among adults speaking different dialects from the Chaoshan region of southern China. Public Health Nutr 2021; 24:290-298. [PMID: 32347195 PMCID: PMC10195506 DOI: 10.1017/s136898001900507x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2019] [Revised: 11/25/2019] [Accepted: 12/06/2019] [Indexed: 02/05/2023]
Abstract
OBJECTIVE Dietary salt intake may vary depending on different lifestyles. We aimed to estimate the different salt intakes and evaluate the knowledge and self-awareness about salt among people speaking the Teochew, Teochew-Hakka and Hakka dialects in the Chaoshan region of southern China. DESIGN The study followed a cluster sampling of residents in Chaoshan region. General characteristics, lifestyles, health status as well as knowledge and self-awareness related to salt intake were investigated using a questionnaire. Anthropometric variables as well as Na and K excretion in a 24-h urine collection were measured. SETTING Chaoshan region of China. PARTICIPANTS Four hundred fifteen adults who spoke only one of these three dialects. RESULTS The salt intake of adults who spoke the Teochew, Teochew-Hakka and Hakka dialects was 7·19 (interquartile range (IQR) 5·29-10·17), 9·03 (IQR 6·62-11·54) and 10·12 (IQR 7·61-12·82) g/d, respectively, with significant differences between Teochew and Teochew-Hakka speakers and between Teochew and Hakka speakers (both P < 0·05). The Na:K ratio for adults who spoke the three dialects was 3·00 (IQR 2·00-4·11), 3·50 (IQR 2·64-4·82) and 4·52 (IQR 3·35-5·97), respectively, and differed significantly among the groups (all P < 0·05). Multiple linear regression analysis showed increased Na:K ratio associated with hypertension (β = 0·71, P = 0·043) in Hakka speakers. Knowledge and self-awareness about salt intake were poor in this population. CONCLUSIONS Salt intake was closely related to lifestyles and was higher than the upper limit (5 g/d) recommended by the WHO in adults of Chaoshan, especially those speaking the Hakka dialect.
Collapse
Affiliation(s)
- Fen Cai
- Department of Nosocomial Infection Management, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China
| | - Wen-Ya Dong
- Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China
| | - Jia-Xin Jiang
- Lianshang Town Health Hospital of Chenghai District, Shantou, Guangdong, China
| | - Xiao-Li Chen
- Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China
| | - Yue Wang
- Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China
| | - Chang-Yu Deng
- Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China
| | - Qing-Ying Zhang
- Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong, China
- Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China
- Corresponding author: Email
| |
Collapse
|
8
|
Woodham NS, Taneepanichskul S, Somrongthong R, Kitsanapun A, Sompakdee B. Effectiveness of a Multidisciplinary Approach Intervention to Improve Blood Pressure Control Among Elderly Hypertensive Patients in Rural Thailand: A Quasi-Experimental Study. J Multidiscip Healthc 2020; 13:571-580. [PMID: 32694916 PMCID: PMC7340360 DOI: 10.2147/jmdh.s254286] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2020] [Accepted: 06/10/2020] [Indexed: 12/13/2022] Open
Abstract
Purpose Uncontrolled blood pressure among Thai elderly hypertensive patients is a significant public health issue in primary health care facilities under the Universal Health Coverage Scheme in Thailand. This study examines the effectiveness of a multidisciplinary approach intervention to improve blood pressure control among elderly persons in rural Thailand. Patients and Methods This was quasi-experimental study conducted on 200 elderly persons who receive care for hypertension at primary health care facility in rural areas of Thailand. Participants were assigned to either the intervention or control groups. The intervention group was subjected to a multidisciplinary approach intervention program. This program included community-based care for hypertension, family-supportive care for hypertension, antihypertension medication adherence education program, the use of a reminder electronic pill box, and monthly pill counts and blood pressure measurements. The intervention continued for three months. The control group received care for hypertension at the hypertension clinic of the health center. Three measurements were taken at baseline, one month, and three months after the intervention. Data analysis included descriptive statistics and independent sample t-tests. Repeated-measure analysis of variance (ANOVA) and analysis of covariance (ANCOVA) were used to compare the differences between the two groups. Results At one month and three months after the intervention, the multidisciplinary approach intervention controlled blood pressure more effectively compared with the control group. Furthermore, the intervention group had lower systolic and diastolic blood pressure compared with the control group (P-value < 0.001). Conclusion These results suggest that the multidisciplinary approach intervention can be effective in controlling blood pressure in elderly hypertensive patients. Future studies should investigate a cost-effective means of integrating multidisciplinary approach interventions in routine hypertension care for elderly hypertensive patients.
Collapse
Affiliation(s)
| | | | - Ratana Somrongthong
- College of Public Health Sciences, Chulalongkorn University, Bangkok, Thailand
| | | | | |
Collapse
|
9
|
Davarinejad O, Hosseinpour N, Majd TM, Golmohammadi F, Radmehr F. The relationship between Life Style and mental health among medical students in Kermanshah. JOURNAL OF EDUCATION AND HEALTH PROMOTION 2020; 9:264. [PMID: 33282969 PMCID: PMC7709766 DOI: 10.4103/jehp.jehp_534_20] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 07/26/2020] [Indexed: 05/04/2023]
Abstract
INTRODUCTION Given the close relationship between life style and mental health and the importance of students as valuable human resources, the present study aimed at determining the relationship between life style and mental health among medical students in Kermanshah. METHODS This is a descriptive-correlational study that was conducted in 2018. The study involved 200 medical students. The sampling method was convenience sampling. Demographic questionnaire, general health questionnaire, and life style questionnaire were used for data collection. The data were analyzed Pearson's correlation test and regression analysis. The significance level was considered 0.05. RESULTS The mean mental health score of the students was 25.43 ± 13.02 (2 points higher than the cutoff point of this test). The life style of 59.5 students was moderate. The results showed that all life style subscales had a negative significant relationship with the total mental health score and all its subscales (P < 0.05). Among the life style subscales, the highest relationship and predictive power to mental health were obtained for psychological health, social health, sport and fitness, and environmental health (R 2 = 0.48, P < 0.001). CONCLUSION According to the results, the life style of most medical students in the final year of Kermanshah University of Medical Sciences was moderate. Further, the students had a better life style, and they had higher mental health. Therefore, considering the vital role of medical students in providing and promoting community health, the need for more detailed planning and interventions to improve their life style and mental health is essential.
Collapse
Affiliation(s)
- Omran Davarinejad
- Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Nima Hosseinpour
- Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Tahereh Mohammadi Majd
- Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran
- Address for correspondence: Ms. Tahereh Mohammadi Majd, Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran. E-mail:
| | - Farzaneh Golmohammadi
- Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Farnaz Radmehr
- Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran
| |
Collapse
|
10
|
Campbell NRC, Schutte AE, Varghese CV, Ordunez P, Zhang X, Khan T, Sharman JE, Whelton PK, Parati G, Weber MA, Orías M, Jaffe MG, Moran AE, Liane Plavnik F, Ram VS, Brainin M, Owolabi MO, Ramirez AJ, Barbosa E, Bortolotto LA, Lackland DT. São Paulo call to action for the prevention and control of high blood pressure: 2020. J Clin Hypertens (Greenwich) 2019; 21:1744-1752. [PMID: 31769155 PMCID: PMC8030388 DOI: 10.1111/jch.13741] [Citation(s) in RCA: 52] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Accepted: 11/05/2019] [Indexed: 01/11/2023]
Affiliation(s)
- Norm R. C. Campbell
- Department of Medicine, Physiology and Pharmacology and Community Health SciencesO'Brien Institute for Public Health and Libin Cardiovascular Institute of AlbertaUniversity of CalgaryCalgaryABCanada
| | - Aletta E. Schutte
- MRC Unit for Hypertension and Cardiovascular DiseaseHypertension in Africa Research Team (HART)North‐West UniversityPotchefstroomSouth Africa
| | - Cherian V. Varghese
- Department of Non‐Communicable DiseasesWorld Health OrganizationGenevaSwitzerland
| | - Pedro Ordunez
- Department of Non‐Communicable and Mental HealthPan American Health OrganizationWashingtonDCUSA
| | | | - Taskeen Khan
- Department of Non‐Communicable DiseasesWorld Health OrganizationGenevaSwitzerland
| | - James E. Sharman
- Menzies Institute for Medical ResearchUniversity of TasmaniaHobartTASAustralia
| | - Paul K. Whelton
- Departments of Epidemiology and MedicineTulane University Health Sciences CenterNew OrleansLAUSA
| | - Gianfranco Parati
- Department of Medicine and SurgeryUniversity of Milano‐Bicocca & Istituto Auxologico ItalianoIRCCSMilanItaly
- Department of Cardiovascular, Neural and Metabolic SciencesSan Luca HospitalMilanItaly
| | - Michael A. Weber
- Division of Cardiovascular MedicineDownstate Medical CenterState University of New YorkBrooklynNYUSA
| | - Marcelo Orías
- Department of NephrologySanatorio AllendeCórdobaArgentina
- Universidad Nacional de CórdobaCórdobaArgentina
| | - Marc G. Jaffe
- Resolve to Save Lives, An Initiative of Vital StrategiesNew YorkNYUSA
- Kaiser Permanente Northern CaliforniaSouth San FranciscoCAUSA
| | - Andrew E. Moran
- Global Hypertension ControlResolve to Save Lives, An initiative of Vital StrategiesNew YorkNYUSA
| | - Frida Liane Plavnik
- Hypertension GroupHospital Alemão Oswaldo CruzSão PauloBrazil
- Heart Institute (InCor)São PauloBrazil
- Brazilian Society of HypertensionSão PauloBrazil
| | - Venkata S. Ram
- University of Texas Southwestern Medical SchoolDallasTXUSA
- Apollo Medical College and HospitalsHyderabadIndia
- Faculty of Medicine and Health SciencesMacquarie UniversitySydneyNSWAustralia
- World Hypertension LeagueSouth Asia Regional OfficeHyderabadIndia
| | | | - Mayowa O. Owolabi
- African Research Universities Center of Excellence for Non‐communicable DiseasesUniversity of IbadanIbadanNigeria
| | - Augstin J. Ramirez
- Arterial Hypertension an Metabolic UnitUniversity HospitalFavaloro FoundationBuenos AiresArgentina
| | - Eduardo Barbosa
- Latin American Society of HypertensionArtery LatamPorto AlegreBrazil
| | - Luiz Aparecido Bortolotto
- Director of Hypertension UnitHospital das Clínicas FMUSP‐ SPHeart Institute (InCor)São PauloBrazil
- Brazilian Society of HypertensionSão PauloBrazil
| | - Daniel T. Lackland
- Division of Translational Neurosciences and Population StudiesMedical University of South CarolinaCharlestonSCUSA
| |
Collapse
|
11
|
Gholamnejad H, Kakhki AD, Ahmadi F, Rohani C. Development and Psychometric Evaluation of the Elderly Hypertension Self-Care Index. J Nurs Meas 2019; 27:418-432. [PMID: 31871283 DOI: 10.1891/1061-3749.27.3.418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
PURPOSE This study was done to develop and evaluate the psychometric properties of the Elderly Hypertension Self-Care Index. METHODS This was an exploratory mixed method study. Items were developed through conducting a qualitative study with conventional content analysis approach and comprehensively reviewing the existing literature. Then, the developed index was assessed for face, content, and construct validity as well as reliability. RESULTS Analyses identified four themes of self-care: intelligent acceptance, self-actualization in the pass of the disease, effective supporters, and destructive constraints. Exploratory factor analysis revealed that only 28 items were appropriate which were loaded on six factors, accounting for 45.035% of the total variance of hypertension self-care. Cronbach's alpha and test-retest intraclass correlation coefficients of the index were 0.80 and 0.96, respectively. CONCLUSION The Elderly Hypertension Self-Care Index showed that it is a valid and reliable index in the elderly health context; and can be used for self-care assessment among elderly people with hypertension.
Collapse
Affiliation(s)
- Hanieh Gholamnejad
- Students Research Office, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Ali Darvishpoor Kakhki
- Department of Medical-Surgical Nursing School of Nursing & Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Fazlollah Ahmadi
- Department of Nursing, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
| | - Camelia Rohani
- School of Nursing & Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
12
|
Carbajal HA, Salazar MR. Hypertension control in Argentina, in the middle of a long road. J Clin Hypertens (Greenwich) 2019; 21:1604-1606. [PMID: 31490622 DOI: 10.1111/jch.13691] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2019] [Accepted: 08/03/2019] [Indexed: 12/25/2022]
Abstract
In Argentina, cardiovascular diseases are the leading cause of death and represent 1/3 of total mortality. In 2017, hypertension prevalence for inhabitants ≥18 years old was 36.3%, and its level of knowledge and control (<140/90 mm Hg) were 61% and 24%, respectively. Furthermore, 56% of people treated with antihypertensive drugs do not reach therapeutic goal. In addition to this, prevalence of other risk factors, such as sedentary lifestyle, overweight-obesity, high blood glucose/diabetes, and high cholesterol, has worsened in the last 5 years. The governmental initiative "Less Salt More Life" intends to reduce salt consumption in the entire population and promoted a National Law, which establishes the progressive salt reduction in processed foods. This initiative is probably related to the reduction of salt use after cooking or sitting at the table, observed in the Risk Factors National Survey. Furthermore, previously published studies showed, in relatively small samples from Argentina, that populational blood pressure can be decreased and hypertension control can be improved using community-based or multicomponent intervention programs. However, no specific designed national effort for hypertension control is now officially applied. In consequence, we believe that, in order to increase hypertension control, the effort should not focus on developing new strategies, but on quickly implementing and maintaining those local multicomponent interventions that have already proven to be effective.
Collapse
Affiliation(s)
- Horacio A Carbajal
- Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina
| | - Martin R Salazar
- Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.,Servicio de Docencia e Investigación, Hospital Gral. San Martín, La Plata, Argentina
| |
Collapse
|
13
|
Campbell NRC. A step in the global effort to control hypertension: Fixed dose combination antihypertensive drugs. J Clin Hypertens (Greenwich) 2019; 21:1426-1428. [DOI: 10.1111/jch.13683] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2019] [Accepted: 08/03/2019] [Indexed: 11/29/2022]
Affiliation(s)
- Norm R. C. Campbell
- Department of Medicine, Physiology and Pharmacology and Community Health Sciences O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary Calgary Alberta Canada
| |
Collapse
|
14
|
Singh S, Warren HR, Hiltunen TP, McDonough CW, El Rouby N, Salvi E, Wang Z, Garofalidou T, Fyhrquist F, Kontula KK, Glorioso V, Zaninello R, Glorioso N, Pepine CJ, Munroe PB, Turner ST, Chapman AB, Boerwinkle E, Johnson JA, Gong Y, Cooper‐DeHoff RM. Genome-Wide Meta-Analysis of Blood Pressure Response to β 1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies). J Am Heart Assoc 2019; 8:e013115. [PMID: 31423876 PMCID: PMC6759913 DOI: 10.1161/jaha.119.013115] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Accepted: 07/15/2019] [Indexed: 12/26/2022]
Abstract
BackgroundThere exists a wide interindividual variability in blood pressure (BP) response to β1-blockers. To identify the genetic determinants of this variability, we performed a pharmacogenomic genome-wide meta-analysis of genetic variants influencing β1-blocker BP response.Methods and ResultsGenome-wide association analysis for systolic BP and diastolic BP response to β1-blockers from 5 randomized clinical trials consisting of 1254 patients with hypertension of European ancestry were combined in meta-analysis and single nucleotide polymorphisms (SNPs) with P<10-4 were tested for replication in 2 independent randomized clinical trials of β1-blocker-treated patients of European ancestry (n=1552). Regions harboring the replicated SNPs were validated in a β1-blocker-treated black cohort from 2 randomized clinical trials (n=315). A missense SNP rs28404156 in BST1 was associated with systolic BP response to β1-blockers in the discovery meta-analysis (P=9.33×10-5, β=-3.21 mm Hg) and replicated at Bonferroni significance (P=1.85×10-4, β=-4.86 mm Hg) in the replication meta-analysis with combined meta-analysis approaching genome-wide significance (P=2.18×10-7). This SNP in BST1 is in linkage disequilibrium with several SNPs with putative regulatory functions in nearby genes, including CD38, FBXL5, and FGFBP1, all of which have been implicated in BP regulation. SNPs in this genetic region were also associated with BP response in the black cohort.ConclusionsData from randomized clinical trials of 8 European ancestry and 2 black cohorts support the assumption that BST1 containing locus on chromosome 4 is associated with β1-blocker BP response. Given the previous associations of this region with BP, this is a strong candidate region for future functional studies and potential use in precision medicine approaches for BP management and risk prediction.
Collapse
Affiliation(s)
- Sonal Singh
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision MedicineUniversity of FloridaGainesvilleFL
| | - Helen R. Warren
- William Harvey Research InstituteBarts and The London School of Medicine and DentistryQueen Mary University of LondonUnited Kingdom
- National Institute for Health
ResearchBarts Cardiovascular Biomedical Research CenterQueen Mary University of LondonUnited Kingdom
| | - Timo P. Hiltunen
- Department of MedicineUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
- Research Program for Clinical and Molecular MedicineUniversity of HelsinkiFinland
| | - Caitrin W. McDonough
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision MedicineUniversity of FloridaGainesvilleFL
| | - Nihal El Rouby
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision MedicineUniversity of FloridaGainesvilleFL
| | - Erika Salvi
- Neuroalgology UnitFondazione IRCCS Istituto Neurologico “Carlo Besta,”MilanItaly
| | - Zhiying Wang
- Human Genetics and Institute of Molecular MedicineUniversity of Texas Health Science CenterHoustonTX
| | - Tatiana Garofalidou
- William Harvey Research InstituteBarts and The London School of Medicine and DentistryQueen Mary University of LondonUnited Kingdom
| | - Frej Fyhrquist
- Minerva Foundation Institute for Medical ResearchHelsinkiFinland
| | - Kimmo K. Kontula
- Department of MedicineUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
- Research Program for Clinical and Molecular MedicineUniversity of HelsinkiFinland
| | | | - Roberta Zaninello
- Hypertension and related diseases CentreDepartment of Clinical and Experimental MedicineUniversity of SassariItaly
| | - Nicola Glorioso
- Hypertension and related diseases CentreDepartment of Clinical and Experimental MedicineUniversity of SassariItaly
| | - Carl J. Pepine
- Division of Cardiovascular MedicineDepartment of MedicineUniversity of FloridaGainesvilleFL
| | - Patricia B. Munroe
- William Harvey Research InstituteBarts and The London School of Medicine and DentistryQueen Mary University of LondonUnited Kingdom
- National Institute for Health
ResearchBarts Cardiovascular Biomedical Research CenterQueen Mary University of LondonUnited Kingdom
| | | | | | - Eric Boerwinkle
- Human Genetics and Institute of Molecular MedicineUniversity of Texas Health Science CenterHoustonTX
| | - Julie A. Johnson
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision MedicineUniversity of FloridaGainesvilleFL
- Division of Cardiovascular MedicineDepartment of MedicineUniversity of FloridaGainesvilleFL
| | - Yan Gong
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision MedicineUniversity of FloridaGainesvilleFL
| | - Rhonda M. Cooper‐DeHoff
- Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision MedicineUniversity of FloridaGainesvilleFL
- Division of Cardiovascular MedicineDepartment of MedicineUniversity of FloridaGainesvilleFL
| |
Collapse
|
15
|
Myanganbayar M, Baatarsuren U, Chen G, Campbell NRC, Bosurgi R, So G, Unurjargal T, Dashtseren M, Tserengombo N, Batsukh B, Bungert A, Dashdorj N, Dashdorj N. Hypertension knowledge, attitudes, and practices of nurses and physicians in primary care in Ulaanbaatar Mongolia. J Clin Hypertens (Greenwich) 2019; 21:1202-1209. [PMID: 31268239 DOI: 10.1111/jch.13592] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 04/15/2019] [Accepted: 04/29/2019] [Indexed: 11/30/2022]
Abstract
Increased blood pressure is a leading risk for death globally, and interventions to enhance hypertension control have become a high priority. An important aspect of clinical interventions is understanding the knowledge, attitudes, and practices (KAP) of differing primary healthcare practitioners. We examined KAP surveys from 803 primary care practitioners in Ulaanbaatar, Mongolia (response rate 80%), using a comprehensive KAP survey developed by the World Hypertension League (WHL). The WHL KAP survey uniquely includes an assessment of key World Health Organization recommended interventions to enhance hypertension control. There were few substantive differences between healthcare professional disciplines. Primary care practitioners mostly had a positive attitude toward hypertension management. However, confidence and practice in performing specific tasks to control hypertension were suboptimal. A low proportion indicated they systematically screened adults for hypertension and many were not aware of the need to or were confident in prescribing more than two antihypertensive medications. It was the practice of a high proportion of doctors to not pharmacologically treat most people with hypertension who were at high cardiovascular risk. There was a reluctance by physicians to task share hypertension diagnosis, drug prescribing and assessing cardiovascular risk to nurses. The minority of health care professions use a hypertension management algorithm, and few have patient registries with performance reporting functions. There were few substantive differences based on the age, gender, and years of clinical practice of the practitioners. The study findings support the need for standardized education and training of primary care practitioners in Ulaanbaatar to enhance hypertension control.
Collapse
Affiliation(s)
| | | | - Guanmin Chen
- Research Facilitation, Analytics, Alberta Health Services 1101, Foothills Medical Centre, Calgary, AB, Canada
| | - Norm R C Campbell
- Departments of Medicine, Physiology and Pharmacology, Community Health Sciences Libin Cardiovascular Institute of Alberta, O'Brien Institute for Public Health, University of Calgary, Calgary, AL, Canada
| | | | | | - Tsolmon Unurjargal
- Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
| | | | | | - Batbold Batsukh
- The First Central Hospital of Mongolia, Ulaanbaatar, Mongolia
| | - Andreas Bungert
- Onom Foundation: Onom Foundation Central Office, Ulaanbaatar, Mongolia
| | | | | |
Collapse
|
16
|
Campbell NRC, Zhang XH. Hypertension in China: Time to Transition From Knowing the Problem to Implementing the Solution. Circulation 2019; 137:2357-2359. [PMID: 29844071 DOI: 10.1161/circulationaha.118.034028] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Norman R C Campbell
- Departments of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Canada (N.R.C.C.).
| | - Xin-Hua Zhang
- Beijing Hypertension League Institute, China (X.-H.Z.)
| |
Collapse
|
17
|
Yang J, Fuller PJ, Stowasser M. Is it time to screen all patients with hypertension for primary aldosteronism? Med J Aust 2019; 209:57-59. [PMID: 29996750 DOI: 10.5694/mja17.00783] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2017] [Accepted: 02/12/2018] [Indexed: 02/05/2023]
Affiliation(s)
- Jun Yang
- Hudson Institute of Medical Research, Melbourne, VIC
| | | | - Michael Stowasser
- Endocrine Hypertension Research Centre, University of Queensland, Brisbane, QLD
| |
Collapse
|
18
|
The burden of hypertension in Cuba. LANCET PUBLIC HEALTH 2019; 4:e79-e80. [PMID: 30683585 DOI: 10.1016/s2468-2667(18)30234-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2018] [Accepted: 11/01/2018] [Indexed: 11/22/2022]
|
19
|
Kario K, Tomitani N, Buranakitjaroen P, Chia YC, Park S, Chen CH, Divinagracia R, Shin J, Siddique S, Sison J, Ann Soenarta A, Sogunuru GP, Tay JC, Turana Y, Zhang Y, Nailes J, Wanthong S, Hoshide S, Matsushita N, Kanegae H, Wang JG. Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: Results of the Asia BP@Home study. J Clin Hypertens (Greenwich) 2018; 20:1686-1695. [PMID: 30444315 DOI: 10.1111/jch.13415] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2018] [Revised: 09/03/2018] [Accepted: 09/07/2018] [Indexed: 12/23/2022]
Abstract
A self-measured home blood pressure (BP)-guided strategy is an effective practical approach to hypertension management. The Asia BP@Home study is the first designed to investigate current home BP control status in different Asian countries/regions using standardized home BP measurements taken with the same validated home BP monitoring device with data memory. We enrolled 1443 medicated hypertensive patients from 15 Asian specialist centers in 11 countries/regions between April 2017 and March 2018. BP was relatively well controlled in 68.2% of patients using a morning home systolic BP (SBP) cutoff of <135 mm Hg, and in 55.1% of patients using a clinic SBP cutoff of <140 mm Hg. When cutoff values were changed to the 2017 AHA/ACC threshold (SBP <130 mm Hg), 53.6% of patients were well controlled for morning home SBP. Using clinic 140 mm Hg and morning home 135 mm Hg SBP thresholds, the proportion of patients with well-controlled hypertension (46%) was higher than for uncontrolled sustained (22%), white-coat (23%), and masked uncontrolled (9%) hypertension, with significant country/regional differences. Home BP variability in Asian countries was high, and varied by country/region. In conclusion, the Asia BP@Home study demonstrated that home BP is relatively well controlled at hypertension specialist centers in Asia. However, almost half of patients remain uncontrolled for morning BP according to new guidelines, with significant country/regional differences. Strict home BP control should be beneficial in Asian populations. The findings of this study are important to facilitate development of health policies focused on reducing cardiovascular complications in Asia.
Collapse
Affiliation(s)
- Kazuomi Kario
- Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
| | - Naoko Tomitani
- Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
| | - Peera Buranakitjaroen
- Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Yook-Chin Chia
- Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Selangor Darul Ehsan, Malaysia.,Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - Sungha Park
- Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea
| | - Chen-Huan Chen
- Department of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan
| | - Romeo Divinagracia
- University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines
| | - Jinho Shin
- Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea
| | | | - Jorge Sison
- Department of Medicine, Medical Center Manila, Ermita, Manila, Philippines
| | - Arieska Ann Soenarta
- Department of Cardiology and Vascular Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia
| | - Guru Prasad Sogunuru
- MIOT International Hospital, Chennai, India.,College of Medical Sciences, Kathmandu University, Bharatpur, Nepal
| | - Jam Chin Tay
- Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore
| | - Yuda Turana
- Department of Neurology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, North Jakarta, Jakarta, Indonesia
| | - Yuqing Zhang
- Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Jennifer Nailes
- University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines
| | - Sirisawat Wanthong
- Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.,Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | - Satoshi Hoshide
- Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
| | | | - Hiroshi Kanegae
- Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
| | - Ji-Guang Wang
- Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | | |
Collapse
|
20
|
Lucko AM, Doktorchik C, Woodward M, Cogswell M, Neal B, Rabi D, Anderson C, He FJ, MacGregor GA, L'Abbe M, Arcand J, Whelton PK, McLean R, Campbell NRC. Percentage of ingested sodium excreted in 24-hour urine collections: A systematic review and meta-analysis. J Clin Hypertens (Greenwich) 2018; 20:1220-1229. [PMID: 30101426 DOI: 10.1111/jch.13353] [Citation(s) in RCA: 67] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2018] [Revised: 05/28/2018] [Accepted: 06/16/2018] [Indexed: 01/25/2023]
Affiliation(s)
- Aaron M Lucko
- Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, AL, Canada
| | - Chelsea Doktorchik
- Department of Community Health Sciences, O'Brien Institute for Public Health, University of Calgary, Calgary, AL, Canada
| | - Mark Woodward
- The George Institute for Global Health, University of Oxford, Oxford, UK.,George Institute for Global Health, Newtown, New South Wales, Australia
| | - Mary Cogswell
- Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA, USA
| | - Bruce Neal
- George Institute for Global Health, Newtown, New South Wales, Australia
| | - Doreen Rabi
- Departments of Medicine, Community Health and Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada
| | - Cheryl Anderson
- Department of Family Medicine and Public Health, University of California, San Diego, CA, USA
| | - Feng J He
- Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - Graham A MacGregor
- Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - Mary L'Abbe
- Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - JoAnne Arcand
- Faculty of Health Sciences, University of Ontario Institute of Technology, Oshawa, Ontario, Canada
| | - Paul K Whelton
- Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA
| | - Rachael McLean
- Department of Preventive & Social Medicine, University of Otago, Dunedin, New Zealand
| | - Norm R C Campbell
- Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada
| | | |
Collapse
|
21
|
Campbell NRC, Ordunez P, DiPette DJ, Giraldo GP, Angell SY, Jaffe MG, Lackland D, Martinez R, Valdez Y, Maldonado Figueredo JI, Paccot M, Santana MJ, Whelton PK. Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League. J Clin Hypertens (Greenwich) 2018; 20:984-990. [PMID: 29790259 DOI: 10.1111/jch.13307] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Accepted: 04/16/2018] [Indexed: 11/27/2022]
Abstract
The Pan American Health Organization (PAHO)-World Hypertension League (WHL) Hypertension Monitoring and Evaluation Framework is summarized. Standardized indicators are provided for monitoring and evaluating national or subnational hypertension control programs. Five core indicators from the World Health Organization hearts initiative and a single PAHO-WHL core indicator are recommended to be used in all hypertension control programs. In addition, hypertension control programs are encouraged to select from 14 optional qualitative and 33 quantitative indicators to facilitate progress towards enhanced hypertension control. The intention is for hypertension programs to select quantitative indicators based on the current surveillance mechanisms that are available and what is feasible and to use the framework process indicators as a guide to program management. Programs may wish to increase or refine the number of indicators they use over time. With adaption the indicators can also be implemented at a community or clinic level. The standardized indicators are being pilot tested in Cuba, Colombia, Chile, and Barbados.
Collapse
Affiliation(s)
- Norm R C Campbell
- Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada
| | - Pedro Ordunez
- Department of Non Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA
| | - Donald J DiPette
- University of South Carolina, University of South Carolina School of Medicine, Columbia, SC, USA
| | - Gloria P Giraldo
- Department of Non Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA
| | - Sonia Y Angell
- New York City Department of Health and Mental Hygiene, Queens, NY, USA
| | - Marc G Jaffe
- Resolve to Save Lives, an Initiative of Vital Strategies, Cardiovascular Health Initiative, New York, NY, USA
| | - Dan Lackland
- Medical University of South Carolina, Charleston, SC, USA
| | - Ramón Martinez
- Department of Non Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA
| | - Yamilé Valdez
- University Hospital "General Calixto García", Havana, Cuba
| | - Javier I Maldonado Figueredo
- Professional Specialized Integrated Management Group for Cardiovascular, Oral Health, Cancer and other Chronic Conditions, Non-Communicable Disease Office, Ministry of Health and Social Protection of Colombia, Bogota, Colombia
| | - Melanie Paccot
- Ministry of Health of Chile, Department of Noncommunicable Diseases, División de Control y Prevención de Enfermedades, Ministerio de Salud, Santiago, Chile
| | - Maria J Santana
- Departments of Pediatrics, Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
| | - Paul K Whelton
- Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA
| |
Collapse
|
22
|
Lackland DT, Carey RM, Conforto AB, Rosendorff C, Whelton PK, Gorelick PB. Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research. Stroke 2018; 49:772-779. [PMID: 29467237 PMCID: PMC5829017 DOI: 10.1161/strokeaha.117.019379] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2017] [Revised: 12/08/2017] [Accepted: 01/11/2018] [Indexed: 01/19/2023]
Affiliation(s)
- Daniel T Lackland
- From the Department of Neurology, Medical University of South Carolina, Charleston (D.T.L.); Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.); Department of Neurology, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (A.B.C.); Department of Medicine (Cardiology), Mount Sinai Heart and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (C.R.); James J. Peters VA Medical Center, Bronx, NY (C.R.); Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (P.K.W.); and Division of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.).
| | - Robert M Carey
- From the Department of Neurology, Medical University of South Carolina, Charleston (D.T.L.); Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.); Department of Neurology, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (A.B.C.); Department of Medicine (Cardiology), Mount Sinai Heart and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (C.R.); James J. Peters VA Medical Center, Bronx, NY (C.R.); Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (P.K.W.); and Division of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.)
| | - Adriana B Conforto
- From the Department of Neurology, Medical University of South Carolina, Charleston (D.T.L.); Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.); Department of Neurology, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (A.B.C.); Department of Medicine (Cardiology), Mount Sinai Heart and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (C.R.); James J. Peters VA Medical Center, Bronx, NY (C.R.); Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (P.K.W.); and Division of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.)
| | - Clive Rosendorff
- From the Department of Neurology, Medical University of South Carolina, Charleston (D.T.L.); Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.); Department of Neurology, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (A.B.C.); Department of Medicine (Cardiology), Mount Sinai Heart and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (C.R.); James J. Peters VA Medical Center, Bronx, NY (C.R.); Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (P.K.W.); and Division of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.)
| | - Paul K Whelton
- From the Department of Neurology, Medical University of South Carolina, Charleston (D.T.L.); Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.); Department of Neurology, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (A.B.C.); Department of Medicine (Cardiology), Mount Sinai Heart and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (C.R.); James J. Peters VA Medical Center, Bronx, NY (C.R.); Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (P.K.W.); and Division of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.)
| | - Philip B Gorelick
- From the Department of Neurology, Medical University of South Carolina, Charleston (D.T.L.); Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.); Department of Neurology, Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (A.B.C.); Department of Medicine (Cardiology), Mount Sinai Heart and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (C.R.); James J. Peters VA Medical Center, Bronx, NY (C.R.); Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (P.K.W.); and Division of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine and Mercy Health Hauenstein Neurosciences, Grand Rapids (P.B.G.)
| |
Collapse
|
23
|
Kario K. The HOPE Asia Network for “zero” cardiovascular events in Asia. J Clin Hypertens (Greenwich) 2018; 20:212-214. [DOI: 10.1111/jch.13185] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Kazuomi Kario
- Division of Cardiovascular Medicine; Department of Medicine; Jichi Medical University School of Medicine; Tochigi Japan
| | | |
Collapse
|
24
|
Richard MA, Huan T, Ligthart S, Gondalia R, Jhun MA, Brody JA, Irvin MR, Marioni R, Shen J, Tsai PC, Montasser ME, Jia Y, Syme C, Salfati EL, Boerwinkle E, Guan W, Mosley TH, Bressler J, Morrison AC, Liu C, Mendelson MM, Uitterlinden AG, van Meurs JB, Franco OH, Zhang G, Li Y, Stewart JD, Bis JC, Psaty BM, Chen YDI, Kardia SLR, Zhao W, Turner ST, Absher D, Aslibekyan S, Starr JM, McRae AF, Hou L, Just AC, Schwartz JD, Vokonas PS, Menni C, Spector TD, Shuldiner A, Damcott CM, Rotter JI, Palmas W, Liu Y, Paus T, Horvath S, O'Connell JR, Guo X, Pausova Z, Assimes TL, Sotoodehnia N, Smith JA, Arnett DK, Deary IJ, Baccarelli AA, Bell JT, Whitsel E, Dehghan A, Levy D, Fornage M. DNA Methylation Analysis Identifies Loci for Blood Pressure Regulation. Am J Hum Genet 2017; 101:888-902. [PMID: 29198723 PMCID: PMC5812919 DOI: 10.1016/j.ajhg.2017.09.028] [Citation(s) in RCA: 146] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Accepted: 09/28/2017] [Indexed: 12/13/2022] Open
Abstract
Genome-wide association studies have identified hundreds of genetic variants associated with blood pressure (BP), but sequence variation accounts for a small fraction of the phenotypic variance. Epigenetic changes may alter the expression of genes involved in BP regulation and explain part of the missing heritability. We therefore conducted a two-stage meta-analysis of the cross-sectional associations of systolic and diastolic BP with blood-derived genome-wide DNA methylation measured on the Infinium HumanMethylation450 BeadChip in 17,010 individuals of European, African American, and Hispanic ancestry. Of 31 discovery-stage cytosine-phosphate-guanine (CpG) dinucleotides, 13 replicated after Bonferroni correction (discovery: N = 9,828, p < 1.0 × 10-7; replication: N = 7,182, p < 1.6 × 10-3). The replicated methylation sites are heritable (h2 > 30%) and independent of known BP genetic variants, explaining an additional 1.4% and 2.0% of the interindividual variation in systolic and diastolic BP, respectively. Bidirectional Mendelian randomization among up to 4,513 individuals of European ancestry from 4 cohorts suggested that methylation at cg08035323 (TAF1B-YWHAQ) influences BP, while BP influences methylation at cg00533891 (ZMIZ1), cg00574958 (CPT1A), and cg02711608 (SLC1A5). Gene expression analyses further identified six genes (TSPAN2, SLC7A11, UNC93B1, CPT1A, PTMS, and LPCAT3) with evidence of triangular associations between methylation, gene expression, and BP. Additional integrative Mendelian randomization analyses of gene expression and DNA methylation suggested that the expression of TSPAN2 is a putative mediator of association between DNA methylation at cg23999170 and BP. These findings suggest that heritable DNA methylation plays a role in regulating BP independently of previously known genetic variants.
Collapse
Affiliation(s)
- Melissa A Richard
- Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
| | - Tianxiao Huan
- Population Sciences Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA; Framingham Heart Study, Framingham, MA 01702, USA
| | - Symen Ligthart
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam 3000, the Netherlands
| | - Rahul Gondalia
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
| | - Min A Jhun
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48108, USA
| | - Jennifer A Brody
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA 98195, USA
| | - Marguerite R Irvin
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
| | - Riccardo Marioni
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK; Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK; Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Jincheng Shen
- Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT 84108, USA
| | - Pei-Chien Tsai
- Department of Twin Research and Genetic Epidemiology, Kings College London, SE17EH London, UK
| | - May E Montasser
- Division of Endocrinology, Diabetes, and Nutrition, Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
| | - Yucheng Jia
- Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA
| | - Catriona Syme
- Hospital for Sick Children, University of Toronto, Toronto, ON M5G 0A4, Canada
| | - Elias L Salfati
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
| | - Eric Boerwinkle
- Human Genetics Center, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA
| | - Weihua Guan
- Department of Biostatistics, University of Minnesota, Minneapolis, MN 55454, USA
| | - Thomas H Mosley
- Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA
| | - Jan Bressler
- Human Genetics Center, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA
| | - Alanna C Morrison
- Human Genetics Center, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA
| | - Chunyu Liu
- Population Sciences Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA; Framingham Heart Study, Framingham, MA 01702, USA; Department of Biostatistics, Boston University, Boston, MA 02118, USA
| | - Michael M Mendelson
- Population Sciences Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA; Framingham Heart Study, Framingham, MA 01702, USA; Department of Cardiology, Boston Children's Hospital, Boston, MA 02115, USA
| | - André G Uitterlinden
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam 3000, the Netherlands
| | - Joyce B van Meurs
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam 3000, the Netherlands
| | - Oscar H Franco
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam 3000, the Netherlands
| | - Guosheng Zhang
- Department of Genetics, University of North Carolina, Chapel Hill, NC 27514, USA; Curriculum in Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, NC 27514, USA; Department of Statistics, University of North Carolina, Chapel Hill, NC 27514, USA
| | - Yun Li
- Department of Genetics, University of North Carolina, Chapel Hill, NC 27514, USA; Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, USA
| | - James D Stewart
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA; Carolina Population Center, University of North Carolina, Chapel Hill, NC 27514, USA
| | - Joshua C Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA 98195, USA
| | - Bruce M Psaty
- Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, WA 98101, USA; Kaiser Permanente Washington Health Research Unit, Seattle, WA 98101, USA
| | - Yii-Der Ida Chen
- Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA
| | - Sharon L R Kardia
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48108, USA
| | - Wei Zhao
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48108, USA
| | - Stephen T Turner
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
| | - Devin Absher
- HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA
| | - Stella Aslibekyan
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
| | - John M Starr
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK; Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Allan F McRae
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Lifang Hou
- Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
| | - Allan C Just
- Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Joel D Schwartz
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| | - Pantel S Vokonas
- Veterans Affairs Normative Aging Study, Veterans Affairs Boston Healthcare System, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
| | - Cristina Menni
- Department of Twin Research and Genetic Epidemiology, Kings College London, SE17EH London, UK
| | - Tim D Spector
- Department of Twin Research and Genetic Epidemiology, Kings College London, SE17EH London, UK
| | - Alan Shuldiner
- Division of Endocrinology, Diabetes, and Nutrition, Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA; The Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA
| | - Coleen M Damcott
- Division of Endocrinology, Diabetes, and Nutrition, Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
| | - Jerome I Rotter
- Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA
| | - Walter Palmas
- Department of Medicine, Columbia University, New York, NY 10032, USA
| | - Yongmei Liu
- Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
| | - Tomáš Paus
- Departments of Psychology and Psychiatry, University of Toronto, Toronto, ON M5S 3G3, Canada; Rotman Research Institute, Baycrest, Toronto, ON M6A 2E1, Canada; Child Mind Institute, New York, NY 10022, USA
| | - Steve Horvath
- Department of Human Genetics, Gonda Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Jeffrey R O'Connell
- Division of Endocrinology, Diabetes, and Nutrition, Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
| | - Xiuqing Guo
- Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA
| | - Zdenka Pausova
- Hospital for Sick Children, University of Toronto, Toronto, ON M5G 0A4, Canada; Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, ON M5S 1A8, Canada
| | | | - Nona Sotoodehnia
- Cardiovascular Health Research Unit, Division of Cardiology, University of Washington, Seattle, WA 98195, USA
| | - Jennifer A Smith
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48108, USA
| | - Donna K Arnett
- University of Kentucky, College of Public Health, Lexington, KY 40563, USA
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh EH8 9JZ, UK; Department of Psychology, University of Edinburgh, Edinburgh EH9 8JZ, UK
| | - Andrea A Baccarelli
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| | - Jordana T Bell
- Department of Twin Research and Genetic Epidemiology, Kings College London, SE17EH London, UK
| | - Eric Whitsel
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA
| | - Abbas Dehghan
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam 3000, the Netherlands; Department of Biostatistics and Epidemiology, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK
| | - Daniel Levy
- Population Sciences Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA; Framingham Heart Study, Framingham, MA 01702, USA
| | - Myriam Fornage
- Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA; Human Genetics Center, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA.
| |
Collapse
|
25
|
Campbell NR. Volunteerism, and alignment, are needed for a major paradigm shift in approaches to hypertension control: 2016 World Hypertension League Excellence Award in Hypertension Prevention and Control and the Distinguished Service Award. J Clin Hypertens (Greenwich) 2017; 19:740-742. [DOI: 10.1111/jch.13003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Norm R.C. Campbell
- Department of Medicine; Physiology and Pharmacology and Community Health Sciences; O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta; University of Calgary; Calgary Alberta Canada
| |
Collapse
|
26
|
Worley SL. Experts Provide a Glimpse of the New Post-SPRINT Era of Hypertension. P & T : A PEER-REVIEWED JOURNAL FOR FORMULARY MANAGEMENT 2017; 42:118-123. [PMID: 28163557 PMCID: PMC5265237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
In advance of the new guidelines being published this year, the author discusses treatment targets, diagnostics, and public policy with three hypertension experts.
Collapse
|